DNA
Ginkgo Bioworks Holdings, Inc.
stock NYSE

An unholy homunculus consisting of 50% Ploot DNA and 50% Kais Maalaj DNA

I mean, it's in the Christian DNA at this point; especially Christian Nationalist. Be the dominant, most popular religion with preferential treatment in a country that's supposed to separate Church and State.......yet bitch constantly about how persecuted you are.
Since GOP has become mostly Christian Nationalists at this point (and not small government; efficient use of tax dollars, etc), it is no surprise that the GOP is using the same playbook.

Between rising revenue, strong balance sheet, and expanding proteomics pipeline, Quantum-Si (QSI) is setting up for what could be a long-term 10x run if execution continues.
Still risky, still early, but the fundamentals are improving fast. With funding secured through 2028 and growing adoption of their Platinum platform, QSI could be one of those small-cap tech names that sneaks up on everyone.
Not financial advice, DYOR — the next wave of sequencing innovation might be in proteins, not DNA.

“What stocks are a good buy right now” it gave IREN and DNA

Hmmm. Anyone ever try claiming to be the illegitimate child of a very wealthy individual known to get around? I mean, most would probably tell you to get a DNA test or fuck off. But I bet if you chased enough of em down, someone would give you some shut up money just to not be bothered.

Extraordinary isn’t it? But it’s GOP DNA at this point: We can do and say whatever we want to you or about you and you must comply. If you don’t you are monsters.

I see a double helix. It must be in my DNA.

Pharma, full index. Old people gonna pay bigly for custom made DNA/RNA therapies--millions per treatment.

Sperm is just a fertilizer with half of DNA, he was never a sperm. Also sperm is produced constantly and dies after few days but a woman is born with all her eggs...he missed btc back in 2008 as an unfertilized EGG.
I wonder why people ALWAYS try to pretend we came from a sperm entirely and ignore the egg even though we are mostly the EGG

Most important is that its a company you would want to own at that price. Take a volatile stock like Pagaya (PGY). Last month it was at around $43 and you would get around $380 for a 30 day ATM put. Today, it is at $28. Even with the premium you collected, you'd still be way underwater.
All good if the price goes back up. But if it does something like DNA or other SPACs, it is a big money loser.

Traders often wait for revenue, but in diagnostics the re-rate tends to start on coverage and pilots. CMS is rechecking the coverage policy for stool DNA tests. If language broadens, commercial payers typically mirror quickly. That creates an on-ramp for preferred provider pilots in regions where colonoscopies are backed up or compliance is low.
Why this fits NASDAQ: MYNZ: the product has strong published accuracy, Switzerland is live with a local lab, and there is a U.K. channel in place. That shows payers real logistics and turnaround, not just trial numbers. One modest pilot can standardize ordering and create recurring sample flow off a near-zero base.
Premarket strength around 1.63–1.65 says the crowd is starting to connect dots. My checklist for confirmation: CMS breadcrumbs, any insurer or PBM language in company comms, and Swiss run-rate mentions. If two of those hit together, I expect momentum screens to pull this toward 1.70–1.75 quickly.